• Exela Technologies, Inc. to Host Fourth Quarter 2023 and Full Year 2023 Financial Results Conference CallRead more
  • Exela Technologies Holdings, Inc. Reports Full Year 2023 ResultsRead more
  • Exela Technologies Announces Adjournment of Annual Meeting until June 13, 2024Read more

Exela Technologies Partners with McKesson Specialty Health to Streamline Claims Processing

Community health solutions provider selects Exela’s proprietary healthcare solution to streamline complex healthcare operations while ensuring compliance with manufacturers

IRVING, Texas, July 23, 2018 (GLOBE NEWSWIRE) -- Exela Technologies, Inc. (“Exela”) (NASDAQ:XELA), a global business process automation (BPA) leader, today announced that it was selected by McKesson Specialty Health to provide a suite of business management tools from enrollment and claims processing, to adjudication and payment/copay services.

Individual drug requirements along with enrollment and adjudication programs have strict guidelines that are unique to each pharmaceutical copay program and specific medication. Exela’s proprietary platform, PCH Global, adheres to these guidelines and renders the program to each individual requirement. With decades of experience in the healthcare industry, the Exela solution was chosen after demonstrating the capability to adapt and service the needs of hospitals, clinics, doctors and patients.

Each program Exela designs is custom to the pharmaceutical copay program and each specific drug used by the provider, and offers the solutions provider the flexibility to adapt quickly to the ongoing and changing business requirements.

“McKesson was seeking a responsive vendor that could deliver an end-to-end solution and be able to adapt and render the program to the individual drug requirements, leading to increased customer satisfaction,” said Suresh Yannamani, President, Exela Technologies. “We are pleased to partner with McKesson, and to leverage our key technology-enabled solutions to implement this program.”

“The patient needs faster access to innovative drugs, and complicated claims management can be time consuming and hinder that process,” said Bill Nolan, Vice President and General Manager, McKesson Specialty Health. “This solution streamlines the entire process and helps drug manufacturers in their effort to remain compliant, giving peace of mind to both our team and the patients.”

About Exela Technologies:

(“Exela”) is a global business process automation ("BPA") leader combining industry-specific and industry-agnostic enterprise software and solutions with decades of experience. Our BPA suite of solutions are deployed in banking, healthcare, insurance and other industries to support mission critical environments. Exela is a leader in work flow automation, attended and un-attended cognitive automation, digital mail rooms, print communications, and payment processing with deployments across the globe.

Exela partners with customers to improve user experience and quality through operational efficiency. Exela serves over 3,500 customers through a secure, cloud-enabled global delivery model. We are 22,000 employees strong at nearly 1,100 onsite client facilities and 150 delivery centers located throughout the Americas, Europe and Asia. Our client list includes 60% of the Fortune® 100, along with many of the world’s largest retail chains, banks, law firms, healthcare insurance payers and providers and telecom companies.

Find out more at www.exelatech.com

Follow Exela on Twitter: https://twitter.com/exelatech

Follow Exela on LinkedIn: https://www.linkedin.com/company/11174620/

About McKesson Specialty Health

McKesson Specialty Health, a division of McKesson Corporation, works together with stakeholders across the healthcare delivery system to preserve and strengthen specialty care, passionately driven by the benefits it provides patients and the system as a whole. Through innovative provider, practice management, manufacturer and payer solutions, McKesson Specialty Health focuses on improving the financial, operational and business health of our customers and partners so they may provide the best care to patients. At McKesson Specialty Health, we believe that we are all in this together. For more information, visit mckessonspecialtyhealth.com.

Contact:

Jill Ransome, VP Marketing Communications
E: jill.ransome@exelatech.com
T: 203.360.4555

Digitalª NowSM

Primary Logo

Source: Exela Technologies, Inc.